What is Sanche Jacques Wolf’s Amrize Ltd share ownership after this Form 4 transaction?

After the grant, he directly owns 5,616 Ordinary Shares of Amrize Ltd. The Form 4 also shows an additional 40 Ordinary Shares held indirectly, classified as owned "By child," reflecting a small indirect interest alongside his direct holdings.

Does the Amrize Ltd (AMRZ) Form 4 show any insider share sales by Sanche Jacques Wolf?

The Form 4 does not show any open-market sales by Sanche Jacques Wolf. It reports a compensation-related acquisition of 2,976 Ordinary Shares through a restricted stock unit grant and a small indirect holding of 40 Ordinary Shares attributed to a child.

Amrize Ltd (AMRZ) director receives 2,976-share restricted stock grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Amrize Ltd director Sanche Jacques Wolf received an equity award of 2,976 Ordinary Shares as a restricted stock unit grant. The award was made at a price of $0.0000 per share under the Amrize Ltd 2025 Omnibus Incentive Plan and is described as a grant, award, or other acquisition.

The restricted stock units vest on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd's next regular annual meeting of shareholders. Following this grant, Wolf holds 5,616 Ordinary Shares directly and an additional 40 Ordinary Shares indirectly through a child.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sanche Jacques Wolf

Role null

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	2,976	$0.00	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 5,616 shares (Direct, null); Ordinary Shares — 40 shares (Indirect, By child)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 2,976 Ordinary Shares Grant price per share: $0.0000 per share Direct holdings after grant: 5,616 Ordinary Shares +1 more

4 metrics

RSU grant size 2,976 Ordinary Shares Restricted stock unit award to director on 2026-04-21

Grant price per share $0.0000 per share Stated price for restricted stock unit award

Direct holdings after grant 5,616 Ordinary Shares Total direct ownership following the award

Indirect holdings 40 Ordinary Shares Indirect ownership classified as held "By child"

Key Terms

Restricted stock unit award, Amrize Ltd 2025 Omnibus Incentive Plan, grant, award, or other acquisition, annual meeting of shareholders

4 terms

Restricted stock unit award financial

"Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan."

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

Amrize Ltd 2025 Omnibus Incentive Plan financial

"Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

annual meeting of shareholders financial

"The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

04/22/2026 - 11:36 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanche Jacques Wolf

(Last)

(First)

(Middle)

GRAFENAUWEG 8

(Street)

ZUG

6300

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/21/2026		A		2,976⁽¹⁾	A	$0	5,616	D
Ordinary Shares								40	I	By child

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

	Hans Weinburger, Attorney-in-Fact	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Amrize Ltd (AMRZ) director Sanche Jacques Wolf report on this Form 4?

Sanche Jacques Wolf reported receiving 2,976 Amrize Ltd Ordinary Shares as a restricted stock unit grant. The award is classified as a grant or other acquisition, not an open-market purchase or sale, and increases his direct holdings to 5,616 Ordinary Shares.

How many Amrize Ltd (AMRZ) shares did Sanche Jacques Wolf acquire in this transaction?

He acquired 2,976 Ordinary Shares through a restricted stock unit award at a stated price of $0.0000 per share. This grant is compensation-related rather than a market trade, and it raises his direct ownership position to 5,616 Ordinary Shares after the transaction.

What are the vesting terms of Sanche Jacques Wolf’s Amrize Ltd restricted stock unit award?

The restricted stock unit award vests on the earlier of the one-year anniversary of the grant date and the date of Amrize Ltd’s next regular annual meeting of shareholders. These terms link vesting to both time in service and the company’s shareholder meeting schedule.

Under which plan was the Amrize Ltd (AMRZ) equity award to Sanche Jacques Wolf granted?

The 2,976-share restricted stock unit award was granted under the Amrize Ltd 2025 Omnibus Incentive Plan. This plan provides a framework for equity-based compensation, aligning director incentives with shareholder interests through stock-based awards instead of only cash compensation.